US Stock MarketDetailed Quotes

PRLD Prelude Therapeutics

Watchlist
  • 3.860
  • +0.060+1.58%
Close May 14 16:00 ET
  • 3.770
  • -0.090-2.33%
Post 18:54 ET
212.03MMarket Cap-2075P/E (TTM)

Prelude Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Prelude Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.42

+27.59%
Analyst Rating

Buy

Apr 30, 2024

Prelude Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--

Unlock Free Earnings Estimates

Prelude Therapeutics Earnings Reports

  • Prelude Therapeutics | 10-Q: Quarterly report

    May 7 07:24 ET

  • Prelude Therapeutics | 10-K: Annual report

    Feb 15 17:28 ET

  • Prelude Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 1, 2023 16:37 ET

  • Prelude Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 3, 2023 08:14 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Apr 30, 2024

    Buy

    • Buy

      33.33%

    • Hold

      66.67%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg